Physician Assistant · Downey, CA
NPI
1528481421
Since 2014
Specialty
Physician Assistant
Code 363A00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
11480 Brookshire Ave, Suite 309
Downey, CA, 90241
Phone (562) 869-1201
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$6.8M
1,590 prescriptions
Company payments, 2025
$5,246
From 44 companies
Medicare prescription drug claims, 2024
In 2024, the drug Eriko Nakajima prescribed most often to Medicare patients was Letrozole, with 180 prescriptions and refills. In total Eriko Nakajima wrote 1,590 Medicare prescriptions that cost $6.8M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-06.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Letrozole Generic | 180 | 314 | 42 | $2,764 |
| Alendronate Sodium Generic | 124 | 254 | 40 | $789 |
| Anastrozole Generic | 66 | 174 | 22 | $1,215 |
| Exemestane Generic | 49 | 123 | 15 | $10K |
| Tagrisso Osimertinib Mesylate | 47 | 47 | Under 11 | $812K |
| Prednisone Generic | 43 | 50 | 14 | $177 |
| Hydroxyurea Generic | 42 | 97 | 14 | $1,842 |
| Xtandi Enzalutamide | 36 | 36 | Under 11 | $460K |
| Abiraterone Acetate Generic | 31 | 31 | Under 11 | $130K |
| Promacta Eltrombopag Olamine | 29 | 29 | Under 11 | $282K |
| Ibrance Palbociclib | 27 | 27 | Under 11 | $411K |
| Dexamethasone Generic | 27 | 29 | 12 | $608 |
| Creon Lipase/Protease/Amylase | 26 | 31 | Under 11 | $27K |
| Imbruvica Ibrutinib | 26 | 26 | Under 11 | $402K |
| Tamoxifen Citrate Generic | 25 | 48 | Under 11 | $677 |
Brand drugs: 601 claims; generic drugs: 989 claims; opioid claims: 34.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eriko Nakajima $5,246 ($5,246 in general payments such as food, travel and fees) from 44 companies. The largest payer was Janssen Biotech, Inc. with $799.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 19 | $799 |
| AstraZeneca Pharmaceuticals LP AZN | 21 | $624 |
| Novartis Pharmaceuticals Corporation NVS | 23 | $475 |
| GlaxoSmithKline, LLC. GSK | 12 | $300 |
| Daiichi Sankyo Inc. 4568.T | 17 | $227 |
| Pfizer Inc. PFE | 13 | $224 |
| Gilead Sciences, Inc. GILD | 9 | $220 |
| Astellas Pharma US Inc 4503.T | 5 | $219 |
| Incyte Corporation INCY | 5 | $130 |
| Celgene Corporation BMY | 3 | $130 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.